These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
222 related articles for article (PubMed ID: 38864245)
1. Decoding frontotemporal and cell-type-specific vulnerabilities to neuropsychiatric disorders and psychoactive drugs. Ji J; Chao H; Chen H; Liao J; Shi W; Ye Y; Wang T; You Y; Liu N; Ji J; Petretto E Open Biol; 2024 Jun; 14(6):240063. PubMed ID: 38864245 [TBL] [Abstract][Full Text] [Related]
2. Choline Compounds of the Frontal Lobe and Temporal Glutamatergic System in Bipolar and Schizophrenia Proton Magnetic Resonance Spectroscopy Study. Galińska-Skok B; Małus A; Konarzewska B; Rogowska-Zach A; Milewski R; Tarasów E; Szulc A; Waszkiewicz N Dis Markers; 2018; 2018():3654894. PubMed ID: 30595760 [TBL] [Abstract][Full Text] [Related]
3. N-acetylaspartate and N-Acetylaspartylglutamate deficits in superior temporal cortex in schizophrenia and bipolar disorder: a postmortem study. Nudmamud S; Reynolds LM; Reynolds GP Biol Psychiatry; 2003 Jun; 53(12):1138-41. PubMed ID: 12814865 [TBL] [Abstract][Full Text] [Related]
4. Association of genetic risks for schizophrenia and bipolar disorder with specific and generic brain structural endophenotypes. McDonald C; Bullmore ET; Sham PC; Chitnis X; Wickham H; Bramon E; Murray RM Arch Gen Psychiatry; 2004 Oct; 61(10):974-84. PubMed ID: 15466670 [TBL] [Abstract][Full Text] [Related]
5. Glucocorticoid receptor mRNA and protein isoform alterations in the orbitofrontal cortex in schizophrenia and bipolar disorder. Sinclair D; Webster MJ; Fullerton JM; Weickert CS BMC Psychiatry; 2012 Jul; 12():84. PubMed ID: 22812453 [TBL] [Abstract][Full Text] [Related]
6. Postmortem human brain genomics in neuropsychiatric disorders--how far can we go? Jaffe AE Curr Opin Neurobiol; 2016 Feb; 36():107-11. PubMed ID: 26685806 [TBL] [Abstract][Full Text] [Related]
7. Gene-based analysis of regionally enriched cortical genes in GWAS data sets of cognitive traits and psychiatric disorders. Ersland KM; Christoforou A; Stansberg C; Espeseth T; Mattheisen M; Mattingsdal M; Hardarson GA; Hansen T; Fernandes CP; Giddaluru S; Breuer R; Strohmaier J; Djurovic S; Nöthen MM; Rietschel M; Lundervold AJ; Werge T; Cichon S; Andreassen OA; Reinvang I; Steen VM; Le Hellard S PLoS One; 2012; 7(2):e31687. PubMed ID: 22384057 [TBL] [Abstract][Full Text] [Related]
8. Hypomethylation of MB-COMT promoter is a major risk factor for schizophrenia and bipolar disorder. Abdolmaleky HM; Cheng KH; Faraone SV; Wilcox M; Glatt SJ; Gao F; Smith CL; Shafa R; Aeali B; Carnevale J; Pan H; Papageorgis P; Ponte JF; Sivaraman V; Tsuang MT; Thiagalingam S Hum Mol Genet; 2006 Nov; 15(21):3132-45. PubMed ID: 16984965 [TBL] [Abstract][Full Text] [Related]
14. G72 primate-specific gene: a still enigmatic element in psychiatric disorders. Sacchi S; Binelli G; Pollegioni L Cell Mol Life Sci; 2016 May; 73(10):2029-39. PubMed ID: 26914235 [TBL] [Abstract][Full Text] [Related]
15. Transcriptome analysis of cortical tissue reveals shared sets of downregulated genes in autism and schizophrenia. Ellis SE; Panitch R; West AB; Arking DE Transl Psychiatry; 2016 May; 6(5):e817. PubMed ID: 27219343 [TBL] [Abstract][Full Text] [Related]
16. Sites of active gene regulation in the prenatal frontal cortex and their role in neuropsychiatric disorders. Kouakou MR; Cameron D; Hannon E; Dempster EL; Mill J; Hill MJ; Bray NJ Am J Med Genet B Neuropsychiatr Genet; 2021 Sep; 186(6):376-388. PubMed ID: 34632689 [TBL] [Abstract][Full Text] [Related]
17. Post-mortem molecular profiling of three psychiatric disorders. Ramaker RC; Bowling KM; Lasseigne BN; Hagenauer MH; Hardigan AA; Davis NS; Gertz J; Cartagena PM; Walsh DM; Vawter MP; Jones EG; Schatzberg AF; Barchas JD; Watson SJ; Bunney BG; Akil H; Bunney WE; Li JZ; Cooper SJ; Myers RM Genome Med; 2017 Jul; 9(1):72. PubMed ID: 28754123 [TBL] [Abstract][Full Text] [Related]